RP
IDXX icon

Riverbridge Partners’s Idexx Laboratories IDXX Stock Holding History

Riverbridge Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.7M Sell
73,440
-9,084
-11% -$5.1M 1.08% 32
2026
Q1 		$46.4M Sell
82,524
-7,175
-8% -$4.6M 1.13% 29
2025
Q4 		$60.7M Sell
89,699
-5,734
-6% -$3.9M 1.14% 27
2025
Q3 		$61M Sell
95,433
-3,897
-4% -$2.37M 1.03% 31
2025
Q2 		$53.3M Sell
99,330
-3,162
-3% -$1.51M 0.86% 40
2025
Q1 		$43M Sell
102,492
-889
-0.9% -$386K 0.69% 55
2024
Q4 		$42.7M Sell
103,381
-4,428
-4% -$1.94M 0.58% 62
2024
Q3 		$54.5M Sell
107,809
-1,715
-2% -$833K 0.73% 52
2024
Q2 		$53.4M Sell
109,524
-1,981
-2% -$995K 0.73% 52
2024
Q1 		$60.2M Sell
111,505
-4,860
-4% -$2.66M 0.73% 54
2023
Q4 		$64.6M Sell
116,365
-3,246
-3% -$1.52M 0.81% 47
2023
Q3 		$52.3M Sell
119,611
-2,112
-2% -$1.05M 0.71% 52
2023
Q2 		$61.1M Sell
121,723
-3,244
-3% -$1.55M 0.77% 48
2023
Q1 		$62.5M Sell
124,967
-1,637
-1% -$783K 0.88% 42
2022
Q4 		$51.6M Sell
126,604
-2,723
-2% -$1.06M 0.78% 44
2022
Q3 		$42.1M Buy
129,327
+9,574
+8% +$3.52M 0.63% 59
2022
Q2 		$42M Sell
119,753
-13,219
-10% -$5.39M 0.67% 59
2022
Q1 		$72.7M Sell
132,972
-6,206
-4% -$3.26M 0.82% 46
2021
Q4 		$91.6M Sell
139,178
-3,684
-3% -$2.31M 0.91% 41
2021
Q3 		$88.8M Buy
142,862
+703
+0.5% +$472K 0.89% 44
2021
Q2 		$89.8M Buy
142,159
+4,064
+3% +$2.24M 0.91% 45
2021
Q1 		$67.6M Buy
138,095
+5,213
+4% +$2.61M 0.77% 51
2020
Q4 		$66.4M Buy
132,882
+5,043
+4% +$2.26M 0.73% 55
2020
Q3 		$50.3M Buy
127,839
+4,768
+4% +$1.76M 0.7% 55
2020
Q2 		$40.6M Buy
123,071
+28,382
+30% +$8.22M 0.64% 55
2020
Q1 		$22.9M Buy
+94,689
New +$24.7M 0.48% 70

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Riverbridge Partners's IDXX Position: Q2 2026 in Review

Riverbridge Partners reduced its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, selling an estimated $5.1M and leaving 73,440 shares worth $38.7M. The position accounts for 1.08% of the portfolio, ranked #32.

Riverbridge Partners first reported a position in IDXX in Q1 2020 and has held it in 26 quarters since. The position peaked at $91.6M in Q4 2021. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Riverbridge Partners held 73,440 shares of Idexx Laboratories worth $38.7M as of Q2 2026.
  • Riverbridge Partners sold 9,084 Idexx Laboratories shares in Q2 2026, an estimated $5.1M.
  • Idexx Laboratories made up 1.08% of Riverbridge Partners's portfolio in Q2 2026, its #32 holding.
  • Riverbridge Partners first reported a position in Idexx Laboratories in Q1 2020 and has held it in 26 quarters since.
  • Riverbridge Partners's Idexx Laboratories position peaked at $91.6M in Q4 2021.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Riverbridge Partners's 13F filing for Q2 2026, filed 13 Jul 2026.